| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/02/2009 | WO2009081957A1 Pyripyropene derivative having acat2-inhibiting activity |
| 07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
| 07/02/2009 | WO2009081891A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/02/2009 | WO2009081837A1 Pharmaceutical composition for ameliorating lower urinary tract symptom |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | WO2009081751A1 Novel method for producing antibiotic preparation |
| 07/02/2009 | WO2009081564A1 DAPKs INHIBITOR |
| 07/02/2009 | WO2009080899A2 Products and methods affecting cell and tissue growth |
| 07/02/2009 | WO2009052970A3 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors |
| 07/02/2009 | WO2009050136A3 Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome |
| 07/02/2009 | WO2009001097A3 Substrate reduction therapy |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170950 Inhibitors Of Neurotrypsin |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/02/2009 | US20090170831 Substituted lactams as inhibitors of abeta protein production |
| 07/02/2009 | US20090170807 Methods and means for producing hyaluronan |
| 07/02/2009 | US20090170793 Theophylline-dependent riboswitches which modulate RNA splicing; made by insertion of a high affinity theophylline binding aptamer into the 3' splice site region, 5' splice site region, or branchpoint sequence (BPS) of a pre-mRNA modulates RNA splicing in the presence of theophylline |
| 07/02/2009 | US20090170766 Chimeric Kunitz Domains and their Use |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170756 Chimeric natriuretic peptides |
| 07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
| 07/02/2009 | US20090170172 Recombinant Methods and Materials for Producing Epothilone and Epothilone Derivatives |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090169632 Sustained release composition and manufacturing method thereof |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169548 Binding molecules |
| 07/02/2009 | US20090169513 Expression of virus entry inhibitors and recombinant AAV therefor |
| 07/02/2009 | US20090169500 Personal care compositions |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | CA2710791A1 Pyripyropene derivatives having an acat2-inhibiting activity |
| 07/02/2009 | CA2710490A1 Drug delivery system |
| 07/02/2009 | CA2709727A1 Pharmaceutical composition for improving lower urinary tract symptoms |
| 07/02/2009 | CA2709530A1 Monosebacate of pyrazole derivative |
| 07/02/2009 | CA2708447A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/02/2009 | CA2707403A1 N-pyrazole-2-pyridinecarboxamide derivative |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2075334A1 EG-VEGF nucleic acids and polypeptides and methods of use |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2074997A1 Use of Asimadoline for the treatment of digestive disorders |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1359883A4 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | CN101468984A N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 07/01/2009 | CN100506978C Hemapoietic stem/ancestral cell enriching method and its in vitro directional induction and differentiation |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506825C Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506813C Remedies |
| 07/01/2009 | CN100506807C Amide derivatives as GK activators |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506284C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/01/2009 | CN100506231C Anti-inflammatory compositions and methods of use |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 07/01/2009 | CN100506224C Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553928 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553856 Crystalline form of omeprazole |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553847 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder; 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 06/30/2009 | US7553821 Methods for selectively modulating survivin apoptosis pathways |
| 06/30/2009 | US7553815 Therapeutic use |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | CA2459399C Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2295101C Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009078423A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 06/25/2009 | WO2009077908A1 Colloidal particle comprising multivalent cyclic anions |